BridgeMD
New treatment option for Liver Transplantation
Official title Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting Time
ClinicalTrials.gov ID: NCT06874296
What this study is testing
- What it's testing
- The goal of this study is to find out if quality assessment by normothermic machine perfusion can be used to safely increase the number of usable donor livers, helping more people get transplants faster and with better results. This process keeps a donated liver working outside the body before transplantation, allowing surgeons to assess whether livers previously considered unsuitable can still be used.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Able to consent
- ≥ 18 years old
- Listed in status "transplantable" by the transplant conference of the study centre for liver transplantation, according to the guidelines of the...
- ReMELD-Na-Score ≤ 21 (equivalent to MELD ≤25), not eligible for [non]standard exceptions
- Medically suitable and informed for transplantation with an organ that fulfils extended donor criteria (Eurotransplant ECD criteria)
You likely can't join if
- Listed for retransplantation
- High-Urgency Listing
- Listed for combined organ transplantation
- Pregnancy
See the full eligibility criteria
- Able to consent
- ≥ 18 years old
- Listed in status "transplantable" by the transplant conference of the study centre for liver transplantation, according to the guidelines of the German Medical Association valid at the time of inclusion
- ReMELD-Na-Score ≤ 21 (equivalent to MELD ≤25), not eligible for [non]standard exceptions
- Medically suitable and informed for transplantation with an organ that fulfils extended donor criteria (Eurotransplant ECD criteria)
- Patient information and written consent to participate in the Extra trial
- No participation in another treatment study during participation
- Listed for retransplantation
- High-Urgency Listing
- Listed for combined organ transplantation
- Pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Hamburg, Free and Hanseatic City of Hamburg, Germany
- Aachen, North Rhine-Westphalia, Germany
- Bonn, North Rhine-Westphalia, Germany
- Münster, North Rhine-Westphalia, Germany
- Berlin, State of Berlin, Germany
- Hanover, Germany
- München, Germany
- Regensburg, Germany
- Tübingen, Germany
- Würzburg, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hamburg, Free and Hanseatic City of Hamburg, Germany; Aachen, North Rhine-Westphalia, Germany; Bonn, North Rhine-Westphalia, Germany; Münster, North Rhine-Westphalia, Germany; Berlin, State of Berlin, Germany; Hanover, Germany and 4 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.